Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vasopressin vs Catecholamines in Septic Shock
NCT00269685Phase 3Completed
- Sponsor
- Université de Sherbrooke
- Start
- Jul 2000
- Modality
- Peptides
01
Overview
Phase 3, randomised trial of vasopressin in septic shock (2 arms), sponsored by Université de Sherbrooke. Primary endpoint: Reversal of the hemodynamic criterion of septic shock. Started Jul 2000; status: completed.
02
Drugs
vasopressin
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT00269685.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00269685.